- Report
- March 2024
- 184 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 196 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- November 2023
- 148 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- October 2023
- 182 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- March 2024
- 180 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 250 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- August 2023
- 250 Pages
Global
From €2403EUR$2,490USD£2,062GBP
- Report
- November 2023
- 144 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- October 2023
- 188 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Report
- June 2023
- 118 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- October 2023
- 162 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- December 2023
- 295 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- July 2023
- 200 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- October 2023
- 85 Pages
United States
From €4585EUR$4,750USD£3,933GBP
- Report
- May 2023
- 92 Pages
North America
From €1448EUR$1,500USD£1,242GBP
- Report
- March 2018
- 182 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
The Anti Rheumatic market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of rheumatic diseases. These diseases are caused by an abnormal immune response, which can lead to inflammation and joint pain. Anti Rheumatic drugs are used to reduce inflammation and pain, as well as to prevent further damage to the joints. These drugs can be administered orally, intravenously, or topically. Commonly used Anti Rheumatic drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic response modifiers.
Some companies in the Anti Rheumatic market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more